249 related articles for article (PubMed ID: 17493958)
1. Neonatal human autologous dendritic cells pulsed with recombinant protein antigen prime the generation of non-polarized CD4 T-cell effectors.
Matthews NC; Power UF; Reen DJ
Int Immunol; 2007 Jun; 19(6):703-12. PubMed ID: 17493958
[TBL] [Abstract][Full Text] [Related]
2. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
[TBL] [Abstract][Full Text] [Related]
3. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
Mejri N; Brossard M
Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
[TBL] [Abstract][Full Text] [Related]
4. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type.
DeKruyff RH; Fang Y; Umetsu DT
J Immunol; 1992 Dec; 149(11):3468-76. PubMed ID: 1358971
[TBL] [Abstract][Full Text] [Related]
5. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.
Wu CY; Demeure C; Kiniwa M; Gately M; Delespesse G
J Immunol; 1993 Aug; 151(4):1938-49. PubMed ID: 8102154
[TBL] [Abstract][Full Text] [Related]
6. HOZOTs, novel human regulatory T-cell lines, exhibit helper or suppressor activities depending on dendritic cell or anti-CD3 stimulation.
Sugimoto A; Suzuki M; Otani T; Okochi A; Takeuchi M; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2009 Dec; 37(12):1454-63. PubMed ID: 19819295
[TBL] [Abstract][Full Text] [Related]
7. Long-term CD4+ memory T cells from the spleen lack MEL-14, the lymph node homing receptor.
Bradley LM; Atkins GG; Swain SL
J Immunol; 1992 Jan; 148(2):324-31. PubMed ID: 1345918
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
9. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
10. IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells.
Detournay O; Mazouz N; Goldman M; Toungouz M
Hum Immunol; 2005 May; 66(5):460-8. PubMed ID: 15935883
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
12. Monocyte-derived DC primed with TLR agonists secrete IL-12p70 in a CD40-dependent manner under hyperthermic conditions.
Peng JC; Hyde C; Pai S; O'Sullivan BJ; Nielsen LK; Thomas R
J Immunother; 2006; 29(6):606-15. PubMed ID: 17063123
[TBL] [Abstract][Full Text] [Related]
13. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
14. In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12.
Wu CY; Demeure CE; Gately M; Podlaski F; Yssel H; Kiniwa M; Delespesse G
J Immunol; 1994 Feb; 152(3):1141-53. PubMed ID: 7905497
[TBL] [Abstract][Full Text] [Related]
15. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
17. Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma.
Bradley LM; Duncan DD; Tonkonogy S; Swain SL
J Exp Med; 1991 Sep; 174(3):547-59. PubMed ID: 1678774
[TBL] [Abstract][Full Text] [Related]
18. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
DiIulio NA; Xu H; Fairchild RL
Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
[TBL] [Abstract][Full Text] [Related]
19. Mammal-derived respiratory lipocalin allergens do not exhibit dendritic cell-activating capacity.
Parviainen S; Kinnunen T; Rytkönen-Nissinen M; Nieminen A; Liukko A; Virtanen T
Scand J Immunol; 2013 Mar; 77(3):171-6. PubMed ID: 23298316
[TBL] [Abstract][Full Text] [Related]
20. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells.
Nakamura T; Kamogawa Y; Bottomly K; Flavell RA
J Immunol; 1997 Feb; 158(3):1085-94. PubMed ID: 9013946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]